Erratum: Improvement of Memory by Means of Ultra-Low Doses of Antibodies to S-100B Antigen (Evidence-Based Complementary and Alternative Medicine (2006) 3 (973943) DOI: 10.1093/ecam/nel073);Improvement of memory by means of ultra-low doses of antibodies to S-100B antigen

Evidence-based Complementary and Alternative Medicine

Volumn 3, Issue 4, 2006, Pages 541-545

  Epstein, O I ^a   Pavlov, I F ^a   Shtark, M B ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY AND BIOPHYSICS   (Russian Federation)

Author keywords

Antibodies; Antigen S 100B; Memory; Ultra low doses

Indexed keywords

DEXAMETHASONE; PROTEIN ANTIBODY; PROTEIN S100B; PROTEIN S100B ANTIBODY;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; AUDITORY STIMULATION; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; FEEDING BEHAVIOR; HOMEOPATHY; LEARNING; LOW DRUG DOSE; MALE; MEDICAL LITERATURE; MEMORY; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SKILL; TASK PERFORMANCE;

EID: 33845401340     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2020/3278048     Document Type: Erratum

References (33)

1. Bellavite P, Conforti A, Pontarollo F, Ortolani R. Immunology and homeopathy. 2. Cells of the Immune System and Inflammation. Evid Based Complement Alternat Med 2006;3:13-24.
2. Datta S, Biswas SJ, Khuda-Bukhsh AR. Comparative efficacy of pre-feeding, post-feeding and combined pre- and post-feeding of two microdoses of a potentized homeopathic drug, mercurius solubilis, in ameliorating genotoxic effects produced by mercuric chloride in mice. Evid Based Complement Alternat Med 2004;1:291-300.
3. Epstein OI, Beregovoy NA, Sorokina NS, Starostina MV, Shtark MB, Gainutdinov KhL, et al. Membrane and synaptic effects of anti-S-100 are prevented by the same antibodies in low concentrations. Front Biosci 2003;8:79-84.
4. Epstein OI, Zapara TA, Simonova OG, Ratushnyak AS, Shtark MB. Plasticity of neuronal responses induced by low concentrations of exogenous ligands affecting cellular calcium stores. Front Biosci 2004;9:809-15.
5. Khuda-Bukhsh AR. Towards understanding molecular mechanisms of action of homeopathic drugs: an overview. Mol Cell Biochem 2003;253:339-45.
6. Lewith G. Complementary medicine research unit. Evid Based Complement Alternat Med 2005;2:399-407.
7. Ahlemeyer B, Beier H, Semkova I, Schaper C, Krieglstein J. S-100beta protects cultured neurons against glutamate- and staurosporine-induced damage and is involved in the antiapoptotic action of the 5 HT(1A)-receptor agonist, Bay x 3702. Brain Res 2000;858:121-8.
8. Arcuri C, Bianchi R, Brozzi F, Donato R. S100B increases proliferation in PC12 neuronal cells and reduces their responsiveness to nerve growth factor via Akt activation. J Biol Chem 2005;280:4402-14.
9. Azmitia EC, Whitaker-Azmitia PM. Awakening the sleeping giant: anatomy and plasticity of the brain serotonergic system. J Clin Psychiatr 1991;52:4-16.
10. Fano G, Biocca S, Fulle S, Mariggio MA, Belia S, Calissano P. The S-100: a protein family in search of a function. Prog Neurobiol 1995;46:71-82.
11. Gromov LA, Syrovatskaya LP, Ovinova GV. Functional role of the neurospecific S-100 protein in the processes of memory. Neurosci Behav Physiol 1992;22:25-9.
12. Mellstrom B, Naranjo JR. Ca2+-dependent transcriptional repression and derepression: DREAM, a direct effector. Semin Cell Dev Biol 2001;12:59-63.
13. Motin VG, Nikitin VP, Sherstnev VV. Effects of antibodies against protein S100b on synaptic transmission and long-term potentiation in CA-1 hippocampal neurons in rats. Bull Exp Biol Med 2002;133:110-3.
14. Onions J, Hermann S, Grundström T. Basic helix-loop-helix protein sequences determining differential inhibition by calmodulin and S-100 proteins. J Biol Chem 1997;272:23930-7.
15. Zimmer DB, Cornwall EH, Landar A, Song W. The S100 protein family: history, function, and expression. Brain Res Bull 1995;37:417-29.
16. Popov N, Schultzek S, Pankova TM, Ratushnyak AS, Starostina MV, Shtark MB, et al. Alterations in calmodulin and S-100 protein content of hippocampal slices during long-term potentiation. Biomed Biochem Acta 1988;47:189-95.
17. Starostina MV, Malup TK, Sviridov SM. Studies on the interaction of Ca ions with some fractions of the neurospecific S-100 protein. J Neurochem 1981;36:1904-15.
18. Starostina MV, Nikolaenkova AA, Malup TK, Korochkin LI, Sviridov SM. Quantitative study of S-100 protein in mouse brain cortex synaptosomes. Cell Mol Neurobiol 1993;13:677-91.
19. Roozendaal B, McGaugh JL. The memory-modulatory effects of glucocorticoids depend on an intact stria terminalis. Brain Res 1996;709:243-50.
20. Setlow B, Roozendaal B, McGaugh JL. Involvement of a basolateral amygdala complex-nucleus accumbens pathway in glucocorticoid-induced modulation of memory consolidation. Eur J Neurosci 2000;12:367-75.
21. Roozendaal B. Systems mediating acute glucocorticoid effects on memory consolidation and retrieval. Prog Neuropsychopharmacol Biol Psychiatr 2003;27:1213-23.
22. Roozendaal B, McGaugh JL. Amygdaloid nuclei lesions differentially affect glucocorticoid-induced memory enhancement in an inhibitory avoidance task. Neurobiol Learn Mem 1996;65:1-8.
23. Igaz LM, Vianna RM, Medina JH, Izquierdo I. Two time periods of hippocampal mRNA synthesis are required for memory consolidation of fear-motivated learning. J Neurosci 2002;22:6781-9.
24. O'Dowd BS, Zhao WQ, Ng KT, Robinson SR. Chicks injected with antisera to either S-100 alpha or S-100 beta protein develop amnesia for a passive avoidance task. Neurobiol Learn Mem 1997;67:197-206.
25. Epstein OI, Vorobyova TM, Berchenko OG, Geyko VV, Bevzyuk DA. Influence of ultra-low doses of neurotropic and neurospecific substances and antibodies to them on conditioned reflex activities in rats. Proproten-100. Affinity purified anti-S 100 antibodies in ultralow doses. Moscow: MGUL, 2002, 64-8.
26. Shtark MB, Gainutdinov KL, Khichenko VI, Starostina MV. S100, a brain-specific protein: localization and possible role in the snail nervous system. Cell Mol Neurobiol 1981;1:289-99.
27. Rebaudo R, Melani R, Balestrino M, Cupello A, Haglid K, Hyden H. Antiserum against S-100 protein prevents long term potentiation through a cAMP-related mechanism. Neurochem Res 2000;25:541-5.
28. Whitaker-Azmitia PM, Murphy R, Azmitia EC. Stimulation of astroglial 5-HT1A receptors releases the serotonergic growth factor, protein S-100, and alters astroglial morphology. Brain Res 1990;528:155-8.
29. Buhot MC, Malleret G, Segu L. Serotonin receptors and cognitive behaviour - an update. IDrugs 1999;2:426-37.
30. Elia V, Baiano S, Duro I, Napoli E, Niccoli M, Nonatelli L. Permanent physico-chemical properties of extremely diluted aqueous solutions of homeopathic medicines. Homeopathy 2004;93:144-50.
31. Jankovic BD, Djordjijevic D. Differential appearance of autoantibodies to human brain S100 protein in psychiatric patients. Int J Neurosci 1991;60:119-27.
32. Mecocci P, Parnetti L, Romano G, Scarelli A, Chionne F, Cecchetti R, et al. Serum anti-GFAP and anti-S-100 autoantibodies in human aging, Alzheimer's disease and vascular dementia. J. Neuroimmunol 1995;57:165-70.
33. Barykina NN, Alekhina TA, Chugui VF, Petrenko OI, Popova NK, Kolpakov VG. Correlation between cataleptic freezing and prepulse inhibition of the startle reflex in rats. Neurosci Behav Physiol 2004;34:413-6.